BlackRock Fund Advisors’s Ocera Therapeutics, Inc. OCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $120K | Buy |
56,990
+3,140
| +6% | +$6.61K | ﹤0.01% | 3560 |
|
2016
Q3 | $142K | Buy |
53,850
+7,614
| +16% | +$20.1K | ﹤0.01% | 3553 |
|
2016
Q2 | $88K | Buy |
46,236
+12,946
| +39% | +$24.6K | ﹤0.01% | 3706 |
|
2016
Q1 | $98K | Sell |
33,290
-2,343
| -7% | -$6.9K | ﹤0.01% | 3670 |
|
2015
Q4 | $111K | Buy |
35,633
+1,056
| +3% | +$3.29K | ﹤0.01% | 3711 |
|
2015
Q3 | $109K | Sell |
34,577
-912
| -3% | -$2.88K | ﹤0.01% | 3679 |
|
2015
Q2 | $135K | Buy |
35,489
+4,264
| +14% | +$16.2K | ﹤0.01% | 3664 |
|
2015
Q1 | $147K | Buy |
31,225
+4,337
| +16% | +$20.4K | ﹤0.01% | 3556 |
|
2014
Q4 | $171K | Buy |
26,888
+1,926
| +8% | +$12.2K | ﹤0.01% | 3527 |
|
2014
Q3 | $122K | Sell |
24,962
-1,819
| -7% | -$8.89K | ﹤0.01% | 3606 |
|
2014
Q2 | $205K | Buy |
+26,781
| New | +$205K | ﹤0.01% | 3483 |
|